Literature DB >> 9875841

Immune receptor editing: revise and select.

M C Nussenzweig1.   

Abstract

Secondary antigen receptor gene recombination occurs in developing lymphocytes, and in more mature T and B cells. In the developing lymphocyte, "editing" occurs in response to receptor ligation by autoantigens. As a result of receptor editing, anti-self-reactive cells are converted to non-self-reactive cells, and self-reactive clones are thereby salvaged before negative selection. This antigen-induced change in the receptor specificity was not foreseen in the clonal selection theory. However, editing could be incorporated into the clonal selection theory by limiting receptor selection to a specific stage in lymphocyte development that precedes cellular selection as suggested by Jerne (1971). We know much less about the origin, regulation, or function of V(D)J recombination in mature lymphocytes. Nevertheless, antigen-induced receptor selection is likely to play an important role in shaping immune responses.

Mesh:

Substances:

Year:  1998        PMID: 9875841     DOI: 10.1016/s0092-8674(00)81711-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  19 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Authors:  S Nisitani; A B Satterthwaite; K Akashi; I L Weissman; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Differential accessibility at the kappa chain locus plays a role in allelic exclusion.

Authors:  Maya Goldmit; Mark Schlissel; Howard Cedar; Yehudit Bergman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

4.  Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity.

Authors:  Pia Dosenovic; Ervin E Kara; Anna-Klara Pettersson; Andrew T McGuire; Matthew Gray; Harald Hartweger; Eddy S Thientosapol; Leonidas Stamatatos; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

5.  The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Authors:  Fiona A Harding; Marcia M Stickler; Jennifer Razo; Robert B DuBridge
Journal:  MAbs       Date:  2010-05-01       Impact factor: 5.857

6.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Contribution of V(H) replacement products to the generation of anti-HIV antibodies.

Authors:  Hongyan Liao; Jun-tao Guo; Miles D Lange; Run Fan; Michael Zemlin; Kaihong Su; Yongjun Guan; Zhixin Zhang
Journal:  Clin Immunol       Date:  2012-11-15       Impact factor: 3.969

Review 8.  The mucolipin-2 (TRPML2) ion channel: a tissue-specific protein crucial to normal cell function.

Authors:  Math P Cuajungco; Joshua Silva; Ania Habibi; Jessica A Valadez
Journal:  Pflugers Arch       Date:  2015-09-04       Impact factor: 3.657

9.  Regulation of VH replacement by B cell receptor-mediated signaling in human immature B cells.

Authors:  Jing Liu; Miles D Lange; Sang Yong Hong; Wanqin Xie; Kerui Xu; Lin Huang; Yangsheng Yu; Götz R A Ehrhardt; Michael Zemlin; Peter D Burrows; Kaihong Su; Robert H Carter; Zhixin Zhang
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

10.  Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cells.

Authors:  Anne E Lieberman; Masayuki Kuraoka; Marco Davila; Garnett Kelsoe; Lindsay G Cowell
Journal:  BMC Immunol       Date:  2009-06-25       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.